U.S. Markets closed

Cornerstone Therapeutics announces Alastair McEwan as CFO

Cornerstone Therapeutics announced the appointment of Alastair McEwan as CFO effective Nov. 6. McEwan is a pharmaceutical industry executive with more than 30 years experience. He has been instrumental in numerous strategic initiatives, notably in the healthcare sector, including public and private mergers and acquisitions, divestments and capital restructuring, and organizational restructuring and combinations.